GeneDx Holdings Corp. (NASDAQ:WGS) is one of the 10 Best Diagnostics and Research Stocks to Buy According to Analysts. Craig-Hallum Reaffirms Buy on GeneDx (WGS) With $153 Price Target On March 12, 2026, Craig-Hallum reaffirmed its Buy rating on GeneDx Holdings Corp. (NASDAQ:WGS) and maintained a price target of $153 on the company’s stock following data presented at the ACMG Annual Meeting. The data indicated that the company’s whole exome and genome testing notably reduces healthcare resource utilizati ...